Corentec Co Ltd (104540) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.100x

Based on the latest financial reports, Corentec Co Ltd (104540) has a cash flow conversion efficiency ratio of 0.100x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩8.50 Billion ≈ $5.76 Million USD) by net assets (₩85.14 Billion ≈ $57.70 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Corentec Co Ltd (104540) liquidity interval to measure how many days the company can operate on defensive assets alone.

Corentec Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Corentec Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Corentec Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Corentec Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
SJM Co Ltd
KO:123700
0.046x
Hammer Metals Ltd
AU:HMX
-0.019x
Q linea AB
ST:QLINEA
-0.099x
Mural Oncology plc
NASDAQ:MURA
-0.335x
Nath Bio-Genes (India) Limited
NSE:NATHBIOGEN
-0.160x
RS GROUP PLC
LSE:RS1
0.087x
Wiseway Group Ltd
AU:WWG
0.102x
Rossmax International Ltd
TWO:4121
0.044x

Annual Cash Flow Conversion Efficiency for Corentec Co Ltd (2013–2024)

The table below shows the annual cash flow conversion efficiency of Corentec Co Ltd from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see Corentec Co Ltd (104540) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩71.98 Billion
≈ $48.78 Million
₩-6.61 Billion
≈ $-4.48 Million
-0.092x -400.04%
2023-12-31 ₩86.12 Billion
≈ $58.36 Million
₩2.63 Billion
≈ $1.79 Million
0.031x -81.03%
2022-12-31 ₩65.75 Billion
≈ $44.56 Million
₩10.60 Billion
≈ $7.18 Million
0.161x +124.02%
2021-12-31 ₩56.63 Billion
≈ $38.38 Million
₩4.08 Billion
≈ $2.76 Million
0.072x +192.57%
2020-12-31 ₩46.41 Billion
≈ $31.45 Million
₩-3.61 Billion
≈ $-2.44 Million
-0.078x -160.37%
2019-12-31 ₩29.94 Billion
≈ $20.29 Million
₩3.86 Billion
≈ $2.61 Million
0.129x -41.02%
2018-12-31 ₩24.09 Billion
≈ $16.32 Million
₩5.26 Billion
≈ $3.56 Million
0.218x +102.32%
2017-12-31 ₩54.32 Billion
≈ $36.81 Million
₩5.86 Billion
≈ $3.97 Million
0.108x +120.77%
2016-12-31 ₩60.18 Billion
≈ $40.79 Million
₩2.94 Billion
≈ $1.99 Million
0.049x +8.09%
2015-12-31 ₩56.27 Billion
≈ $38.13 Million
₩2.54 Billion
≈ $1.72 Million
0.045x +384.68%
2014-12-31 ₩48.30 Billion
≈ $32.73 Million
₩450.70 Million
≈ $305.43K
0.009x -60.24%
2013-12-31 ₩44.48 Billion
≈ $30.15 Million
₩1.04 Billion
≈ $707.46K
0.023x --

About Corentec Co Ltd

KQ:104540 Korea Medical Devices
Market Cap
$35.35 Million
₩52.17 Billion KRW
Market Cap Rank
#23245 Global
#1548 in Korea
Share Price
₩4080.00
Change (1 day)
-1.81%
52-Week Range
₩3910.00 - ₩7160.00
All Time High
₩18150.00
About

Corentec Co., Ltd., develops and sells orthopedic artificial joints in South Korea. Its orthopedic products include hip systems, such as Bencox ID stems, Bencox stems, Bencox modular revision stems, Bencox m stems, and Benfix long stems; and Bencox cups, Bencox bipolar cups, Bencox mirabo cups, and Bencox mirabo multi-hole cups. The company also offers Lospa and Exult knee systems; spine systems,… Read more